Trial Profile

Open label oncolytic virus treatment of refractory cancer under the EU hospital exemption, article 28 of Regulation 1394/2007/EC.

Status: Suspended

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 02 Aug 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ONCOS 102 (Primary) ; Antineoplastics; Oncolytic viruses
Indications Solid tumours
Focus Biomarker; Therapeutic Use
Acronyms ATAP

Most Recent Events

02 Aug 2013 Status changed to suspended. The programme is on hold and not recruiting patients, due to the initiation of clinical trials.
07 May 2011 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com